Cross‐platform normalized analysis of SERPINF1 mRNA levels using the AlzData database revealed that SERPINF1 mRNA was expressed at significantly lower levels in various regions of the brain in patients with AD compared to age‐matched healthy control subjects (Figure S1A, Supporting Information). This evidence concerns the gene SERPINF1 and Alzheimer disease.